rare genetic diseases
See the following -
Recursion Pharmaceuticals Selects Anaconda to Create Innovative Next Generation Drug Discovery Assay Platform to Eradicate Rare Genetic Diseases
Press Release |
Recursion Pharmaceuticals, Continuum Analytics |
October 26, 2016
Continuum Analytics, the creator and driving force behind Anaconda, the leading open data science platform powered by Python, today announced that Recursion Pharmaceuticals, LLC, a drug discovery company focused on rare genetic diseases, has adopted Bokeh––a Continuum Analytics open source visualization framework that operates on the Anaconda platform. Bokeh on Anaconda makes it easy for biologists to identify genetic disease markers and assess drug efficacy when visualizing cell data, allowing for faster time-to-value for pharmaceutical companies...
- Login to post comments